Lumen Technologies stock falls 3.92 percent as Q2 pressure persists

Lumen Technologies stock fell 3.92 percent to USD 6.13 at the September 23, 2026 close on the NYSE, leaving the shares 48.7 percent below their 52-week high of USD 11.95. The market reaction followed a quarter in which revenue contracted even as the company delivered a measurable earnings beat.

Revenue pressure meets an EPS beat

In Q2 2026, Lumen reported revenue of USD 2.805 billion, down 9.3 percent from USD 3.092 billion in the prior-year quarter, according to Yahoo Finance. The decline is substantial, but the revenue total exceeded the Zacks consensus estimate of USD 2.74 billion by USD 0.065 billion.

Adjusted loss per share was USD 0.07 in Q2 2026, compared with a consensus loss of USD 0.13 and a prior-year adjusted loss of USD 0.03. That result reduced the earnings shortfall by USD 0.06 against expectations, although it still marked a wider loss than the comparable quarter.

Strategic revenue grows 14.1 percent

The composition of revenue offers a clearer operating signal. Strategic revenue reached USD 1.289 billion in Q2 2026, up 14.1 percent year over year and representing 53 percent of total business revenue, while legacy revenue fell 15.1 percent to USD 1.155 billion, according to Yahoo Finance. The contrast shows why the total revenue decline does not fully describe Lumen's transition toward newer digital offerings.

Lumen's investor relations page identifies Q2 2026 as its latest quarterly reporting package and describes the company as a network provider spanning metro connectivity, long-haul data transport, edge cloud, security, managed services, and digital platforms, according to Lumen. For investors, the central numerical tension is clear: strategic revenue grew 14.1 percent while total revenue fell 9.3 percent.

Stock remains below its yearly high

Lumen Technologies stock closed at USD 6.13 on the NYSE on September 23, 2026, down USD 0.25 from the prior close of USD 6.38. Its market capitalization was USD 6,315,800,300, while the 52-week range stood at USD 5.52 to USD 11.95.